Christian Laurent - Publications

Affiliations: 
Université de Bordeaux, Talence, Nouvelle-Aquitaine, France 

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Fiorentino M, Coulibaly B, Couderc C, Keita BD, Anoma C, Dah E, Mensah E, Aka TN, Touré JR, Camara D, Kokouba AR, Maradan G, Mora M, Bourrelly M, Riegel L, ... ... Laurent C, et al. Men Who Have Sex with Both Men and Women in West Africa: Factors Associated with a High Behavioral Risk of Acquiring HIV from Male Partners and Transmission to Women (CohMSM ANRS 12324-Expertise France). Archives of Sexual Behavior. PMID 37973698 DOI: 10.1007/s10508-023-02715-2  0.31
2023 Reyniers T, Fiorentino M, Babo SAY, Ouedraogo M, Kanta I, Agbegnigan LE, Rojas D, Anoma C, Dah TTE, Mensah E, Keita BD, Spire B, Vuylsteke B, Laurent C. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study. Aids Patient Care and Stds. 37: 480-488. PMID 37862074 DOI: 10.1089/apc.2023.0097  0.383
2023 Reyniers T, Babo SAY, Ouedraogo M, Kanta I, Ekon Agbégnigan L, Rojas D, Eubanks A, Anoma C, Dah TTE, Mensah E, Dembélé Keita B, Spire B, Vuylsteke B, Laurent C. Strategies to improve PrEP uptake among West African men who have sex with men: a multi-country qualitative study. Frontiers in Public Health. 11: 1165327. PMID 37181706 DOI: 10.3389/fpubh.2023.1165327  0.31
2023 Laurent C, Yaya I, Cuer B, Sagaon-Teyssier L, Mensah E, Elias Dah TT, Coulibaly A, Kouamé MJ, Peytavin G, Serrano L, Eubanks A, Traoré I, Diallo F, Riegel L, Castro DR, et al. HIV seroconversion among men who have sex with men who use event-driven or daily oral pre-exposure prophylaxis (CohMSM-PrEP): A multi-country demonstration study from West Africa. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37052469 DOI: 10.1093/cid/ciad221  0.404
2022 Eubanks A, Coulibaly B, Keita BD, Anoma C, Dah TTE, Mensah E, Maradan G, Bourrelly M, Mora M, Riegel L, Rojas Castro D, Yaya I, Spire B, Laurent C, Sagaon-Teyssier L. Loss to Follow-Up from HIV Pre-Exposure Prophylaxis Care in Men Who Have Sex with Men in West Africa. Viruses. 14. PMID 36366478 DOI: 10.3390/v14112380  0.38
2022 Eubanks A, Coulibaly B, Dembélé Keita B, Anoma C, Dah TTE, Mensah E, Maradan G, Bourrelly M, Mora M, Riegel L, Rojas Castro D, Yaya I, Spire B, Laurent C, Sagaon-Teyssier L. Rate and Predictors of Ineffective HIV Protection in African Men Who Have Sex with Men Taking Pre-Exposure Prophylaxis. Aids and Behavior. PMID 35469111 DOI: 10.1007/s10461-022-03692-8  0.387
2022 Coulaud PJ, Sow A, Sagaon-Teyssier L, Ndiaye K, Maradan G, Laurent C, Spire B, Vidal L, Kuaban C, Boyer S. Individual and healthcare supply-related HIV transmission factors in HIV-positive patients enrolled in the antiretroviral treatment access program in the Centre and Littoral regions in Cameroon (ANRS-12288 EVOLCam survey). Plos One. 17: e0266451. PMID 35385535 DOI: 10.1371/journal.pone.0266451  0.44
2022 Sandie AB, Molinari N, Wanjoya A, Kouanfack C, Laurent C, Tchatchueng-Mbougua JB. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the "Stratall ANRS 12110 / ESTHER" trial. Trials. 23: 202. PMID 35248123 DOI: 10.1186/s13063-022-06118-x  0.527
2021 Dah TTE, Yaya I, Mensah E, Coulibaly A, Kouamé JM, Traoré I, Mora M, Palvadeau P, Anoma C, Keita BD, Spire B, Laurent C. Rapid antiretroviral therapy initiation and its effect on treatment response in men who have sex with men in West Africa. Aids (London, England). PMID 34352834 DOI: 10.1097/QAD.0000000000003046  0.401
2021 Laurent C, Dembélé Keita B, Yaya I, Le Guicher G, Sagaon-Teyssier L, Agboyibor MK, Coulibaly A, Traoré I, Malan JB, De Baetselier I, Eubanks A, Riegel L, Rojas Castro D, Fayé-Ketté H, Koné A, et al. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. The Lancet. Hiv. PMID 34048794 DOI: 10.1016/S2352-3018(21)00005-9  0.337
2021 Dah TTE, Yaya I, Sagaon-Teyssier L, Coulibaly A, Kouamé MJ, Agboyibor MK, Maiga K, Traoré I, Mora M, Palvadeau P, Rojas-Castro D, Diallo F, Mensah E, Anoma C, Keita BD, ... ... Laurent C, et al. Adherence to quarterly HIV prevention services and its impact on HIV incidence in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). Bmc Public Health. 21: 972. PMID 34022820 DOI: 10.1186/s12889-021-10994-4  0.395
2021 Yaya I, Diallo F, Kouamé MJ, Agboyibor MK, Traoré I, Coulibaly A, Maiga K, Mora M, Palvadeau P, Dah ETT, Mensah E, Anoma C, Dembélé Keita B, Spire B, Laurent C, et al. Decrease in incidence of sexually transmitted infections symptoms in men who have sex with men enrolled in a quarterly HIV prevention and care programme in West Africa (CohMSM ANRS 12324-Expertise France). Sexually Transmitted Infections. PMID 33753460 DOI: 10.1136/sextrans-2020-054755  0.307
2021 Fiorentino M, Sow A, Sagaon-Teyssier L, Mora M, Mengue MT, Vidal L, Kuaban C, March L, Laurent C, Spire B, Boyer S. Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM). Plos One. 16: e0246192. PMID 33600445 DOI: 10.1371/journal.pone.0246192  0.396
2020 Coulaud PJ, Protopopescu C, Ndiaye K, Baudoin M, Maradan G, Laurent C, Spire B, Vidal L, Kuaban C, Boyer S. Individual and healthcare supply-related barriers to treatment initiation in HIV-positive patients enrolled in the Cameroonian antiretroviral treatment access programme. Health Policy and Planning. PMID 33367696 DOI: 10.1093/heapol/czaa153  0.408
2020 Liégeois F, Boyer S, Eymard-Duvernay S, Carrieri P, Kouanfack C, Domyeum J, Maradan G, Ducos J, Mpoudi-Ngolé E, Spire B, Delaporte E, Kuaban C, Vidal L, Laurent C. Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM). Bmc Infectious Diseases. 20: 49. PMID 31941464 DOI: 10.1186/S12879-020-4784-7  0.755
2019 Coulaud PJ, Sagaon-Teyssier L, Mimi M, M'madi Mrenda B, Maradan G, Mora M, Bourrelly M, Keita BD, Keita AA, Anoma C, Babo Yoro SA, Dah TTE, Coulibaly C, Mensah E, Agbomadji S, ... ... Laurent C, et al. Combined Sexual Behavioral Profiles in HIV-Seronegative Men Who have Sex with Men in West Africa (CohMSM ANRS 12324-Expertise France). Archives of Sexual Behavior. PMID 31399923 DOI: 10.1007/s10508-019-01513-z  0.355
2019 Coulaud PJ, Sagaon-Teyssier L, Mimi M, Maradan G, Mora M, Bourrelly M, Dembélé Keita B, Keita AA, Anoma C, Yoro SB, Dah ETT, Coulibaly C, Mensah E, Agbomadji S, Palvadeau P, ... ... Laurent C, et al. Changes in risky sexual behaviours among West African MSM enrolled in a quarterly HIV testing and counselling prevention programme (CohMSM ANRS 12324 - Expertise France). Sexually Transmitted Infections. PMID 31371449 DOI: 10.1136/sextrans-2018-053892  0.344
2019 Fiorentino M, Sagaon-Teyssier L, Ndiaye K, Suzan-Monti M, Mengue MT, Vidal L, Kuaban C, March L, Laurent C, Spire B, Boyer S. Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors and relationship with antiretroviral therapy discontinuity-results from the ANRS-12288 EVOLCam survey. Women's Health (London, England). 15: 1745506519848546. PMID 31177929 DOI: 10.1177/1745506519848546  0.526
2019 Kounta CH, Sagaon-Teyssier L, Coulaud PJ, Mora M, Maradan G, Bourrelly M, Keita AA, Yoro SB, Anoma C, Coulibaly C, Dah ETT, Agbomadji S, Mensah E, Bernier A, Couderc C, ... ... Laurent C, et al. Male clients of male sex workers in West Africa: A neglected high-risk population. Plos One. 14: e0212245. PMID 31042757 DOI: 10.1371/Journal.Pone.0212245  0.401
2019 Coulaud PJ, Préau M, Maradan G, Mora M, Traoré F, Oga M, Thio E, Ekon L, Dembele Keita B, Anoma C, Ter Tiero Dah E, Mensah E, Bernier A, Couderc C, Laurent C, et al. Taking empowerment into account: the response of community-based organisations to the HIV care needs of men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). Aids Care. 1-9. PMID 30829534 DOI: 10.1080/09540121.2019.1587358  0.326
2018 Liégeois F, Eymard-Duvernay S, Boyer S, Maradan G, Kouanfack C, Domyeum J, Boyer V, Mpoudi-Ngolé E, Spire B, Delaporte E, Vidal L, Kuaban C, Laurent C. Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM). Hiv Medicine. PMID 30362279 DOI: 10.1111/Hiv.12681  0.721
2018 Penot P, Héma A, Bado G, Sombié D, Kaboré FN, Poda A, Michon C, Terzolo O, Traoré A, Slama L, Sawadogo A, Laurent C. Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso: a surprising relationship. Aids Care. 1-5. PMID 29991274 DOI: 10.1080/09540121.2018.1497132  0.429
2018 Chammartin F, Zürcher K, Keiser O, Weigel R, Chu K, Kiragga AN, Ardura-Garcia C, Anderegg N, Laurent C, Cornell M, Tweya H, Haas AD, Rice BD, Geng EH, Fox MP, et al. Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29889240 DOI: 10.1093/Cid/Ciy347  0.472
2018 Tong C, Suzan-Monti M, Sagaon-Teyssier L, Mimi M, Laurent C, Maradan G, Mengue MT, Spire B, Kuaban C, Vidal L, Boyer S. Treatment interruption in HIV positive patients followed up in Cameroon's antiretroviral treatment program: individual and healthcare supply related factors (ANRS-12288 EVOLCam survey). Tropical Medicine & International Health : Tm & Ih. PMID 29327419 DOI: 10.1111/Tmi.13030  0.471
2017 Guichet E, Serrano L, Laurent C, Eymard-Duvernay S, Kuaban C, Vidal L, Delaporte E, Ngole EM, Ayouba A, Peeters M. Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots. Journal of Virological Methods. 251: 75-79. PMID 29038002 DOI: 10.1016/J.Jviromet.2017.10.014  0.564
2017 Couderc C, Dembélé Keita B, Anoma C, Wade AS, Coulibaly A, Ehouman S, Diop AK, Yomb Y, Henry E, Spire B, Laurent C. Is PrEP Needed for MSM in West Africa? HIV Incidence in a Prospective Multicountry Cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 75: e80-e82. PMID 28617734 DOI: 10.1097/Qai.0000000000001288  0.517
2017 Couderc C, Keita BD, Anoma C, Wade AS, Coulibaly A, Ehouman S, Diop AK, Yomb Y, Henry E, Spire B, Laurent C. Is PrEP needed for MSM in West Africa? HIV incidence in a prospective multi-country cohort. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 28107229 DOI: 10.1097/QAI.0000000000001288  0.407
2016 Boullé C, Guichet E, Kouanfack C, Aghokeng A, Onambany B, Ikaka CM, Ngock E, Tsoumsta L, Msellati P, Mpoudi-Ngolé E, Peeters M, Delaporte E, Laurent C. Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets. Open Forum Infectious Diseases. 3: ofw233. PMID 28018931 DOI: 10.1093/Ofid/Ofw233  0.708
2016 Barankanira E, Molinari N, Niyongabo T, Laurent C. Spatial analysis of HIV infection and associated individual characteristics in Burundi: indications for effective prevention. Bmc Public Health. 16: 118. PMID 26847711 DOI: 10.1186/S12889-016-2760-3  0.509
2015 Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C. Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 355-64. PMID 26181708 DOI: 10.1097/Qai.0000000000000604  0.694
2015 Suzan-Monti M, Blanche J, Boyer S, Kouanfack C, Delaporte E, Bonono RC, Carrieri P, Protopopescu C, Laurent C, Spire B, Biwolé-Sida M, Koulla-Shiro S, Bourgeois A, Peeters M, Laborde-Balen G, et al. Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy] Hiv Medicine. 16: 307-318. DOI: 10.1111/Hiv.12213  0.658
2014 Meresse M, March L, Kouanfack C, Bonono RC, Boyer S, Laborde-Balen G, Aghokeng A, Suzan-Monti M, Delaporte E, Spire B, Carrieri MP, Laurent C. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon. Hiv Medicine. 15: 478-87. PMID 24589279 DOI: 10.1111/Hiv.12140  0.766
2014 Penot P, Héma A, Bado G, Kaboré F, Soré I, Sombié D, Traoré JR, Guiard-Schmid JB, Fontanet A, Slama L, Bruno Sawadogo A, Laurent C. The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso. Journal of the International Aids Society. 17: 18646. PMID 24433983 DOI: 10.7448/Ias.17.1.18646  0.392
2013 Boyer S, Laurent C, Kouanfack C, Delaporte E, Moatti JP. Laboratory monitoring for antiretroviral therapy in low-resource settings. The Lancet. Infectious Diseases. 13: 739. PMID 23969214 DOI: 10.1016/S1473-3099(13)70203-2  0.714
2013 Mbougua JB, Laurent C, Ndoye I, Delaporte E, Gwet H, Molinari N. Nonlinear multiple imputation for continuous covariate within semiparametric Cox model: application to HIV data in Senegal. Statistics in Medicine. 32: 4651-65. PMID 23712767 DOI: 10.1002/Sim.5854  0.525
2013 Bado G, Penot P, N'Diaye MD, Amiel C, Hema A, Kamboulé EB, Guiard-Schmid JB, Kaboré NF, Slama L, Bambara A, Laurent C, Sangaré L, Sawadogo AB. Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso. MéDecine Et Maladies Infectieuses. 43: 202-7. PMID 23701923 DOI: 10.1016/J.Medmal.2013.04.001  0.471
2013 Boullé C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Boyer S, Carrieri MP, Kazé S, Mben JM, Dontsop M, Spire B, Peeters M, Mpoudi-Ngolé E, Delaporte E, Laurent C. Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 604-7. PMID 23667264 DOI: 10.1093/Cid/Cit323  0.747
2013 Ndziessi G, Cohen J, Kouanfack C, Marcellin F, Carrieri MP, Carierri MP, Laborde-Balen G, Protopopescu C, Aghokeng AF, Moatti JP, Spire B, Delaporte E, Laurent C, Boyer S. Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial). Plos One. 8: e62611. PMID 23638126 DOI: 10.1371/Journal.Pone.0062611  0.778
2013 Boyer S, March L, Kouanfack C, Laborde-Balen G, Marino P, Aghokeng AF, Mpoudi-Ngole E, Koulla-Shiro S, Delaporte E, Carrieri MP, Spire B, Laurent C, Moatti JP. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. The Lancet. Infectious Diseases. 13: 577-86. PMID 23602084 DOI: 10.1016/S1473-3099(13)70073-2  0.723
2013 Sundararaman SA, Liu W, Keele BF, Learn GH, Bittinger K, Mouacha F, Ahuka-Mundeke S, Manske M, Sherrill-Mix S, Li Y, Malenke JA, Delaporte E, Laurent C, Mpoudi Ngole E, Kwiatkowski DP, et al. Plasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malaria. Proceedings of the National Academy of Sciences of the United States of America. 110: 7020-5. PMID 23569255 DOI: 10.1073/Pnas.1305201110  0.479
2013 Ndziessi G, Cohen J, Kouanfack C, Boyer S, Moatti JP, Marcellin F, Laurent C, Spire B, Delaporte E, Carrieri MP. Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon -- data from the STRATALL ANRS 12110/ESTHER trial. Aids Care. 25: 347-55. PMID 23544212 DOI: 10.1080/09540121.2012.701717  0.682
2013 Suzan-Monti M, Kouanfack C, Boyer S, Blanche J, Bonono RC, Delaporte E, Carrieri PM, Moatti JP, Laurent C, Spire B. Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitals. Plos One. 8: e55225. PMID 23383117 DOI: 10.1371/Journal.Pone.0055225  0.756
2013 Aghokeng AF, Kouanfack C, Eymard-Duvernay S, Butel C, Edoul GE, Laurent C, Koulla-Shiro S, Delaporte E, Mpoudi-Ngole E, Peeters M. Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon. Journal of the International Aids Society. 16: 18004. PMID 23374858 DOI: 10.7448/Ias.16.1.18004  0.734
2013 Meresse M, Carrieri MP, Laurent C, Kouanfack C, Protopopescu C, Blanche J, Cohen J, Laborde-Balen G, Aghokeng AF, Spire B, Moatti JP, Delaporte E, Boyer S. Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon. Antiviral Therapy. 18: 29-37. PMID 23358393 DOI: 10.3851/Imp2535  0.678
2013 Boullé C, Kouanfack C, Laborde-Balen G, Carrieri MP, Dontsop M, Boyer S, Aghokeng AF, Spire B, Koulla-Shiro S, Delaporte E, Laurent C. Task shifting HIV care in rural district hospitals in Cameroon: evidence of comparable antiretroviral treatment-related outcomes between nurses and physicians in the Stratall ANRS/ESTHER trial. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 569-76. PMID 23337365 DOI: 10.1097/Qai.0B013E318285F7B6  0.691
2013 Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, Etard JF, Pagnaroat M, Fournier-Nicolle I, Eholié S, Konate I, Minga A, Mpoudi-Ngole E, Koulla-Shiro S, Zannou DM, ... ... Laurent C, et al. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 555-61. PMID 23274931 DOI: 10.1097/Qai.0B013E3182821821  0.382
2013 Laurent C. Commentary: HIV testing in low- and middle-income countries: an urgent need for scaling up. Journal of Public Health Policy. 34: 17-21. PMID 23235557 DOI: 10.1057/Jphp.2012.67  0.527
2013 De Beaudrap P, Boullé C, Lewden C, Gabillard D, Nacro B, Diagbouga S, Fassinou P, Hien H, Laurent C, Msellati P. Morbidity after antiretroviral therapy initiation in HIV-1-infected children in West Africa: temporal trends and relation to CD4 count. The Pediatric Infectious Disease Journal. 32: 354-60. PMID 23099424 DOI: 10.1097/Inf.0B013E318278B222  0.487
2012 Mben JM, Kouanfack C, Essomba CN, Mbougua JB, Kenfack A, Tonfack CA, Laborde-Balen G, Bourgeois A, Biwolé-Sida M, Delaporte E, Laurent C. Operational research and HIV policy and guidelines: lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon. Journal of Public Health Policy. 33: 462-77. PMID 22932024 DOI: 10.1057/Jphp.2012.31  0.714
2012 Ndziessi G, Boyer S, Kouanfack C, Cohen J, Marcellin F, Moatti JP, Delaporte E, Spire B, Laurent C, Carrieri MP. Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trial. Plos One. 7: e36118. PMID 22701555 DOI: 10.1371/Journal.Pone.0036118  0.778
2012 Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngolé E, Ducos J, Delaporte E, Laurent C. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon. Antiviral Therapy. 17: 321-6. PMID 22290198 DOI: 10.3851/Imp1911  0.781
2012 Lewden C, Gabillard D, Minga A, Ekouévi DK, Avit D, Konate I, Amani-Bossé C, Messou E, Coffie P, Ouedraogo A, Laurent C, Anglaret X. CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 59: 213-9. PMID 22027874 DOI: 10.1097/Qai.0B013E31823B837E  0.353
2012 Laurent C, Kouanfack C, Molinari N, Koulla-Shiro S, Delaporte E. HIV laboratory monitoring for effective ART in Africa – Authors' reply The Lancet Infectious Diseases. 12: 430-431. DOI: 10.1016/S1473-3099(12)70104-4  0.711
2011 Aghokeng AF, Kouanfack C, Laurent C, Ebong E, Atem-Tambe A, Butel C, Montavon C, Mpoudi-Ngole E, Delaporte E, Peeters M. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients. Aids (London, England). 25: 2183-8. PMID 21860346 DOI: 10.1097/Qad.0B013E32834Bbbe9  0.772
2011 Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, Carrieri P, Laurent C, Spire B. Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods. Journal of Acquired Immune Deficiency Syndromes (1999). 57: S40-3. PMID 21857285 DOI: 10.1097/Qai.0B013E318222B5C2  0.75
2011 Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, Carrieri MP, Mben JM, Dontsop M, Kazé S, Molinari N, Bourgeois A, Mpoudi-Ngolé E, Spire B, Koulla-Shiro S, et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. The Lancet. Infectious Diseases. 11: 825-33. PMID 21831714 DOI: 10.1016/S1473-3099(11)70168-2  0.754
2011 Laurent C. Commentary: scaling up HIV treatment in resource-limited countries: the challenge of staff shortages. Journal of Public Health Policy. 32: 211-8. PMID 21346787 DOI: 10.1057/Jphp.2011.8  0.381
2011 Laurent C, Tchatchueng Mbougua JB, Ngom Guèye NF, Etard JF, Diouf A, Landman R, Molinari N, Girard PM, Sow PS, Ndoye I, Delaporte E. Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal. Tropical Medicine & International Health : Tm & Ih. 16: 217-22. PMID 21087377 DOI: 10.1111/J.1365-3156.2010.02690.X  0.571
2010 Laurent C. Commentary: Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step. Journal of Public Health Policy. 31: 401-6. PMID 21119647 DOI: 10.1057/Jphp.2010.36  0.521
2010 Cournil A, Coudray M, Kouanfack C, Essomba CN, Tonfack CA, Biwolé-Sida M, Delaporte E, Bork K, Laurent C. Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon. Antiviral Therapy. 15: 1039-43. PMID 21041920 DOI: 10.3851/Imp1664  0.769
2010 Kouanfack C, Laborde-Balen G, Aghokeng AF, Bourgeois A, Dontsop M, Mben JM, Kazé S, Mpoudi-Ngolé E, Koulla-Shiro S, Delaporte E, Laurent C. WHO clinical criteria-based initiation of antiretroviral therapy: lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations. Tropical Medicine & International Health : Tm & Ih. 15: 580-3. PMID 20214755 DOI: 10.1111/J.1365-3156.2010.02495.X  0.742
2010 Mbougua JB, Laurent C, Kouanfack C, Bourgeois A, Ciaffi L, Calmy A, Gwet H, Koulla-Shiro S, Ducos J, Mpoudi-Ngolé E, Molinari N, Delaporte E. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon. Bmc Public Health. 10: 105. PMID 20193053 DOI: 10.1186/1471-2458-10-105  0.759
2009 Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy. Hiv Medicine. 11: 85-9. PMID 19659944 DOI: 10.1111/J.1468-1293.2009.00742.X  0.737
2009 Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, Koulla-Shiro S, Mpoudi-Ngole E, Peeters M, Delaporte E. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 1318-22. PMID 19320592 DOI: 10.1086/597779  0.757
2009 Monleau M, Montavon C, Laurent C, Segondy M, Montes B, Delaporte E, Boillot F, Peeters M. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing ∇ Journal of Clinical Microbiology. 47: 1107-1118. PMID 19193835 DOI: 10.1128/Jcm.02255-08  0.597
2008 Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, Schechter M, Laurent C, Keiser O, May M, Sprinz E, Egger M, Anglaret X. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization. 86: 559-67. PMID 18670668 DOI: 10.2471/Blt.07.044248  0.502
2008 Kouanfack C, Laurent C, Peytavin G, Ciaffi L, Ngolle M, Nkene YM, Essomba C, Calmy A, Mpoudi-Ngolé E, Delaporte E, Koulla-Shiro S. Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 216-9. PMID 18520681 DOI: 10.1097/Qai.0B013E3181743955  0.682
2008 Makinson A, Moing VL, Kouanfack C, Laurent C, Delaporte E. Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings. Expert Opinion On Drug Safety. 7: 283-93. PMID 18462186 DOI: 10.1517/14740338.7.3.283  0.732
2008 Laurent C, Bourgeois A, Mpoudi-Ngolé E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoué N, Calmy A, Koulla-Shiro S, Delaporte E. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon. Aids Research and Human Retroviruses. 24: 393-9. PMID 18327976 DOI: 10.1089/Aid.2007.0219  0.699
2008 Braitstein P, Boulle A, Nash D, Brinkhof MWG, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N, et al. Gender and the use of antiretroviral treatment in resource-constrained settings: Findings from a multicenter collaboration Journal of Women's Health. 17: 47-55. PMID 18240981 DOI: 10.1089/Jwh.2007.0353  0.505
2007 Laurent C, Bourgeois A, Mpoudi M, Butel C, Mpoudi-Ngolé E, Delaporte E. HIV and hepatitis C virus coinfection, Cameroon. Emerging Infectious Diseases. 13: 514-6. PMID 17552122 DOI: 10.3201/Eid1303.061069  0.632
2007 Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E. Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine. Aids (London, England). 21: 768-71. PMID 17413701 DOI: 10.1097/Qad.0B013E328045C4D7  0.735
2006 Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, Noumssi N, Tardy M, Sawadogo A, Drabo J, Hien H, Zekeng L, Delaporte E, Peeters M. HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon. Antiviral Therapy. 11: 575-9. PMID 16964825  0.671
2006 Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N, Butel C, Bourgeois A, Mpoudi-Ngolé E, Koulla-Shiro S, Peeters M, Delaporte E. Antiretroviral drug resistance and routine therapy, Cameroon. Emerging Infectious Diseases. 12: 1001-4. PMID 16707062 DOI: 10.3201/Eid1206.050860  0.745
2006 Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. Aids (London, England). 20: 1181-9. PMID 16691070 DOI: 10.1097/01.Aids.0000226959.87471.01  0.598
2006 Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, Balestre E, Sterne JA, May M, Egger M, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (London, England). 367: 817-24. PMID 16530575 DOI: 10.1016/S0140-6736(06)68337-2  0.522
2006 Aghokeng AF, Liu W, Bibollet-Ruche F, Loul S, Mpoudi-Ngole E, Laurent C, Mwenda JM, Langat DK, Chege GK, McClure HM, Delaporte E, Shaw GM, Hahn BH, Peeters M. Widely varying SIV prevalence rates in naturally infected primate species from Cameroon. Virology. 345: 174-89. PMID 16257029 DOI: 10.1016/J.Virol.2005.09.046  0.51
2005 Vidal N, Mulanga C, Bazepeo SE, Mwamba JK, Tshimpaka JW, Kashi M, Mama N, Laurent C, Lepira F, Delaporte E, Peeters M. Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 456-62. PMID 16280702 DOI: 10.1097/01.Qai.0000159670.18326.94  0.652
2005 Dabis F, Balestre E, Braitstein P, Miotti P, Brinkhof WGM, Schneider M, Schechter M, Laurent C, Boulle A, Kabugo C, Capkun G, Seyler C, McIntyre J, Sprinz E, Bansgberg D, et al. Cohort Profile: Antiretroviral therapy in lower income countries (ART-LINC): International collaboration of treatment cohorts International Journal of Epidemiology. 34: 979-986. PMID 16157617 DOI: 10.1093/Ije/Dyi164  0.384
2005 Laurent C, Meilo H, Guiard-Schmid JB, Mapouré Y, Noël JM, M'Bangué M, Joko A, Rozenbaum W, Ntoné FN, Delaporte E. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 108-11. PMID 15937770 DOI: 10.1086/430712  0.58
2005 Bourgeois A, Laurent C, Mougnutou R, Nkoué N, Lactuock B, Ciaffi L, Liégeois F, Andrieux-Meyer I, Zekeng L, Calmy A, Mpoudi-Ngolé E, Delaporte E. Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon. Antiviral Therapy. 10: 335-41. PMID 15865228  0.48
2005 Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M, Diakhaté N, Touré Kane NC, Lanièce I, Ndir A, Vergne L, Ndoye I, Mboup S, Sow PS, Delaporte E. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 14-7. PMID 15608518 DOI: 10.1097/00126334-200501010-00003  0.683
2004 Laurent C, Bourgeois A, Mpoudi M, Butel C, Peeters M, Mpoudi-Ngolé E, Delaporte E. Commercial logging and HIV epidemic, rural Equatorial Africa. Emerging Infectious Diseases. 10: 1953-6. PMID 15550206 DOI: 10.3201/Eid1011.040180  0.629
2004 Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liégeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet (London, England). 364: 29-34. PMID 15234853 DOI: 10.1016/S0140-6736(04)16586-0  0.752
2003 Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, Gueye PM, Sow PS, Faye MA, Liégeois F, Ndir A, Lanièce I, Peeters M, Ndoye I, Mboup S, Delaporte E. Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy. Aids (London, England). 17: S31-8. PMID 14565607 DOI: 10.1097/00002030-200317003-00005  0.682
2003 Laurent C, Seck K, Coumba N, Kane T, Samb N, Wade A, Liégeois F, Mboup S, Ndoye I, Delaporte E. Prevalence of HIV and other sexually transmitted infections, and risk behaviours in unregistered sex workers in Dakar, Senegal. Aids (London, England). 17: 1811-6. PMID 12891067 DOI: 10.1097/00002030-200308150-00010  0.582
2003 Vergne L, Bourgeois A, Mpoudi-Ngole E, Mougnutou R, Mbuagbaw J, Liegeois F, Laurent C, Butel C, Zekeng L, Delaporte E, Peeters M. Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage. Virology. 310: 254-66. PMID 12781713 DOI: 10.1016/S0042-6822(03)00167-3  0.57
2002 Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, Liégeois F, Kane CT, Butel C, Mbuagbaw J, Zekeng L, Mboup S, Mpoudi-Ngolé E, Peeters M, Delaporte E. No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study. The Journal of Infectious Diseases. 186: 486-92. PMID 12195375 DOI: 10.1086/341833  0.588
2002 Laurent C, Diakhaté N, Gueye NF, Touré MA, Sow PS, Faye MA, Gueye M, Lanièce I, Touré Kane C, Liégeois F, Vergne L, Mboup S, Badiane S, Ndoye I, Delaporte E. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. Aids (London, England). 16: 1363-70. PMID 12131213 DOI: 10.1097/00002030-200207050-00008  0.575
2001 Laurent C, Henzel D, Mulanga-Kabeya C, Maertens G, Larouzé B, Delaporte E. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. International Journal of Epidemiology. 30: 872-7. PMID 11511619 DOI: 10.1093/Ije/30.4.872  0.501
Show low-probability matches.